SIVOBIOME
Dead / Abandoned — Abandoned — no statement of use filed (as of 04 Sept 2023)
What this means for you
This application is over — abandoned 04 Sept 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88862446
- Mark type
- Stylized text
- Filed
- 07 Apr 2020
- Published for opposition
- 09 Jun 2020
- Abandoned
- 04 Sept 2023
- Attorney of record
- John W. McGlynn
Goods and services
- Class 005 — Pharmaceuticals: Food supplements; Food supplements for treating digestive disorders; Health food supplements; Nutritional supplements, namely, probiotic compositions; Dietary and nutritional supplements; Pharmaceutical preparations for the treatment and prevention of inflammatory bowel diseases, ulcerative colitis, irritable bowel syndrome, pouchitis, liver diseases, viral diseases; Drugs, Biologic drugs and live biotherapeutics for the treatment and prevention of inflammatory bowel diseases, ulcerative colitis, irritable bowel syndrome, pouchitis, liver disease, viral diseases; Medical Food, namely, dietetic foods in the nature of powder specially adapted for medical use; Probiotic supplements
Owner
- ExeGi Pharma, LLC, Rockville, MD, US
- ExeGi Pharma, LLC, Rockville, MD, US
Prosecution history
- 05 Sept 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 04 Sept 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 22 Feb 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Feb 2023 — SOU EXTENSION 5 GRANTED
- 03 Feb 2023 — SOU EXTENSION 5 FILED
- 21 Feb 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Feb 2023 — SOU TEAS EXTENSION RECEIVED
- 06 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Aug 2022 — SOU EXTENSION 4 GRANTED
- 04 Aug 2022 — SOU EXTENSION 4 FILED
- 04 Aug 2022 — SOU TEAS EXTENSION RECEIVED
- 08 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Feb 2022 — SOU EXTENSION 3 GRANTED
- 04 Feb 2022 — SOU EXTENSION 3 FILED
- 04 Feb 2022 — SOU TEAS EXTENSION RECEIVED